Stephen C. Tarallo

Biography

Stephen Tarallo brings more than 35 years of operational and executive management experience in the pharmaceutical industry to his role as President and CEO. He is a principal stockholder and board member of Lyne Laboratories. Under Stephen’s leadership, Lyne expanded its contract service capabilities to include new drug and generic drug products and has also broadened its technology to offer unit-dose packaging, innovative powder technologies and taste masking. Prior to joining Lyne, Mr. Tarallo was the plant manager of Cytosol Laboratories, Inc., a pharmaceutical manufacturing company specializing in sterile products for human blood processing. Today, amid Stephen’s leadership, Lyne has assembled an experienced group of pharmaceutical executives and managers who are prepared and capable of leading the company into an era of aggressive growth. That growth will be achieved through a business model focused on the development and manufacturing of generic drugs as well as the formation of alliances with strategic marketing partners. Mr. Tarallo holds a BS in Pharmacy from the Massachusetts College of Pharmacy.  

Research Interest

 Lyne Laboratories’ mission is to offer drug development and manufacturing solutions to select companies that are focusing on creating win/win business partnerships.